Emerging economies such as Brazil may affect North American neurodiagnostic devices market
As per the research report released by Spearhead Acuity Business Research & Consulting, emerging markets such as Brazil, India, China, Middle-East and parts of South-East Asia may erode the neurodiagnostic and monitoring devices market of North America, which is currently the global market leader with 44% share. The Asia-Pacific region had captured 16.7% market share in 2014 and is forecasted to capture 18.3% market share by 2019. Continuous healthcare investments and increasing number of hospitals with neurospecialty clinics have derived the growth of the market. Another factor contributing to the growth is the high level of awareness about sleep diagnostics. There are multiple manufacturers in North America and Europe; however, there are more manufacturers of these devices in Asia-Pacific. It is estimated that there are over 20 million epilepsy patients in the Asia-Pacific region. The largest product segment is the magnetoencephalography devices (MEG).